Good, Bad, or Indifferent on Drug Pricing: A Value Benchmark Approach for Newly Launched Drugs in the United States.
Hardly a day goes by without a new article being published in the mainstream press or a medical journal discussing drug pricing. The cost of drugs is a hot potato topic at medical meetings, pharma conference rooms, government hearings, and… Continue Reading
